Biobot Analytics key facts
as of Oct 2026- Developer of a wastewater analysis tool designed to deliver untapped insights into human health and behavior.
- Biobot Analytics is valued at approximately $126.8M as of Oct 2026 (last reported valuation).
- It has raised $41.2M across 3 recorded rounds; the latest was Early Stage VC ($13.5M) in May 2025.
- Notable investors include Y Combinator, Pioneer Fund, Soma Capital, Liquid 2 Ventures, Dorm Room Fund — 38 tracked in total.
- Biobot Analytics has filed 4 Form Ds with the SEC since 2020, most recently Jun 2025 ($13.5M sold to 46 investors).
- Status: Privately Held (backing).
Biobot Analytics's last reported valuation, Oct 2021. Nothing priced has surfaced since.
- ·The complete investor list: 38 names
- ·Watch Biobot Analytics: the Monday email on marks, rounds and moves
Biobot Analytics funding rounds
3 roundsWho backs Biobot Analytics
38+Biobot Analytics valuation
Biobot Analytics's last reported valuation was $127 million in Oct 2021. No priced round, secondary trade or fund mark has surfaced since.
How much has Biobot Analytics raised?
Biobot Analytics has raised $41.2 million across 3 recorded rounds since 2020. The largest was a $6.7 million early-stage round in Apr 2020; the most recent was a $13.5 million early-stage round in May 2025.
Biobot Analytics has filed 4 Form Ds with the SEC since 2020, most recently in Jun 2025 ($13.5 million sold to 46 investors).
Biobot Analytics investors
38 investors are on record for Biobot Analytics, including Y Combinator, Pioneer Fund, Soma Capital and Liquid 2 Ventures. By type, the record holds 9 venture capital firms and 1 hedge fund. The early-stage round in May 2025 drew 46 investors.
About Biobot Analytics
Developer of a wastewater analysis tool designed to deliver untapped insights into human health and behavior. The company's tool generates public health data that is naturally anonymized to yield insight into the health communities and sells data as a service, building and monetizing proprietary datasets and providing analytics via the dashboard for viruses (influenza, RSV, norovirus, Hep C) and chemical metabolites, enabling government officials to get access to actionable insights to prioritize interventions and tackle public health proactively.
- Sector
- Information Technology
- HQ
- Cambridge, MA, United States
- Founded
- 2017
- Employees
- 28
- Website
- biobot.io/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.